| GlaxoSmithKline AG - Avamys, Nasenspray, Suspension | | 57968 | | 01 | | Avamys | | Nasenspray, Suspension | | R01AD12 | | Fluticason Furoat | | 19.12.2007 | | |
| | Composition | | fluticasoni furoas 27.5 µg, glucosum, cellulosum dispergibile, polysorbatum 80, dinatrii edetas, benzalkonii chloridum 8.25 µg, aqua purificata, ad suspensionem pro dosi, doses pro vase 120. | | Packungsbestandteile | | Spray nasale | | | | | | | | Principe actif | Concentr. |
|---|
| Fluticasoni Furoas | 27.5 µg |
| | BAG: Principe actif | Concentr. |
|---|
| Fluticasoni Furoas | 27.5 mcg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Benzalkonium Chlorure | | conserv. |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 120 unidose(s) | 6.83 | 16.60 | B | LS | Non |
|
|
